title: [FDG-PET and CT in gastrointestinal stromal tumor treated with imatinib].
abstract: The combined imaging modality PET/CT is a possible superior tool for evaluation of gastro-intestinal stromal tumor treatment illustrated in a case of a 59-year-old woman responding to imatinib.
authors.affiliation: H:S Rigshospitalet, Diagnostisk Center, PET & Cyklotronenheden, Klinik for Klinisk Fysiologi & Nuklearmedicin, Kobenhavn. eigtved@rh.dk
authors.forename: Annika I
authors.initials: AI
authors.lastname: Eigtved
authors.forename: Anne Kiil
authors.initials: AK
authors.lastname: Berthelsen
authors.forename: Christina
authors.initials: C
authors.lastname: Kinnander
authors.forename: Anders
authors.initials: A
authors.lastname: Krarup-Hansen
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001549:Benzamides; D005260:Female; D019788:Fluorodeoxyglucose F18; D005770:Gastrointestinal Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy*; D006801:Humans; D000068877:Imatinib Mesylate; D008875:Middle Aged; D010879:Piperazines / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*; D019275:Radiopharmaceuticals; D017154:Stromal Cells / Q000473:pathology; D014055:Tomography, Emission-Computed; D014057:Tomography, X-Ray Computed
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18; D000068877:Imatinib Mesylate